In short
Fenofibrate Micronised, a medication primarily used to lower cholesterol and triglyceride levels, is being studied in various clinical trials for its potential benefits in treating different medical conditions. These trials aim to explore the drug's effectiveness, safety, and possible new applications beyond its current approved uses. The studies cover a range of health issues, including diabetic nephropathy, primary biliary cholangitis, and severe hypertriglyceridemia during pregnancy.
At a glance
- Conditions Studied
- Severe hypertriglyceridemia during pregnancy, diabetic nephropathy, primary biliary cholangitis, dyslipidemia, obesity
- Key Objectives
- Evaluate safety and efficacy, assess effects on pregnancy outcomes, explore genetic factors in drug response, investigate metabolic changes
- Dosage Forms
- Oral tablets or capsules, typically 100-300 mg daily, adjusted based on kidney function in some studies
- Combination Therapies
- Often studied in combination with ursodeoxycholic acid (UDCA) for liver conditions, metformin for obesity
- Study Durations
- Range from 30 days to long-term studies up to 120 months
- Primary Outcomes
- Changes in lipid profiles, liver enzyme levels, metabolic markers, adverse events
- Secondary Outcomes
- Effects on retinopathy, changes in body weight, waist circumference, placental transfer of the drug
- Special Populations
- Pregnant women, patients with genetic variations affecting drug metabolism
What is Fenofibrate?
Fenofibrate is a medication primarily used to treat high cholesterol and high triglyceride levels in the blood. It belongs to a class of drugs called fibrates. The micronised form of fenofibrate refers to a special preparation where the drug particles are made extremely small, which can improve how well the body absorbs the medication.
Fenofibrate is known by several brand names, including:
- Antara
- Fenoglide
- Fibricor
- Lipofen
- Lofibra
- TriCor
These different names represent various formulations of the same active ingredient.
Conditions Treated with Fenofibrate
Fenofibrate is primarily used to treat the following conditions:
- Dyslipidemia: This is a condition where there are abnormal levels of lipids (fats) in the blood. Fenofibrate helps reduce triglycerides and increase "good" cholesterol (HDL).
- Severe Hypertriglyceridemia: This refers to very high levels of triglycerides in the blood, which can increase the risk of pancreatitis (inflammation of the pancreas).
- Diabetic Retinopathy: Fenofibrate is also used to slow the progression of eye problems in patients with type 2 diabetes.
Ongoing research is exploring the potential use of fenofibrate in other conditions, such as:
- Primary Biliary Cholangitis (PBC): A chronic liver disease where fenofibrate may help improve liver function when combined with other treatments.
- Diabetic Nephropathy: A kidney condition associated with diabetes where fenofibrate might help protect kidney function.
- Multiple Myeloma: A type of blood cancer where fenofibrate is being studied for its potential anti-cancer effects.
How Fenofibrate Works
Fenofibrate works in several ways to improve lipid levels in the body:
- It reduces the production of triglycerides in the liver.
- It increases the breakdown of fatty acids.
- It enhances the removal of LDL cholesterol (often called "bad" cholesterol) from the bloodstream.
- It increases the production of HDL cholesterol (often called "good" cholesterol).
In addition to its effects on lipids, fenofibrate may have anti-inflammatory properties and could affect how the body uses glucose (sugar), which might explain its potential benefits in conditions like diabetic retinopathy and nephropathy.
Dosage and Administration
Fenofibrate is typically taken orally (by mouth) once daily. The dosage can vary depending on the specific condition being treated and the individual patient's characteristics. Some common dosages include:
- 145 mg or 160 mg once daily for general lipid control
- 200 mg once daily for severe hypertriglyceridemia or in combination with other medications for liver conditions
It's important to note that the dosage may need to be adjusted for patients with kidney problems. For example, patients with poor kidney function might receive a lower dose of 54 mg or 100 mg daily.
Fenofibrate is usually taken with food to improve its absorption. Always follow your doctor's instructions regarding dosage and administration.
Potential Side Effects
Like all medications, fenofibrate can cause side effects. Common side effects may include:
- Stomach pain or nausea
- Headache
- Back pain
- Abnormal liver function tests
More serious but less common side effects can include muscle pain or weakness, which could be a sign of a rare but serious condition called rhabdomyolysis. If you experience unexplained muscle pain, tenderness, or weakness, especially if accompanied by fever or dark-colored urine, contact your doctor immediately.
Ongoing Research and Potential New Uses
Researchers are continually studying fenofibrate to understand its full potential. Some areas of ongoing research include:
- Pregnancy and Severe Hypertriglyceridemia: A study is investigating the safety of using fenofibrate during pregnancy when triglyceride levels are dangerously high.
- Primary Biliary Cholangitis (PBC): Several studies are looking at combining fenofibrate with other treatments to improve outcomes in this liver disease.
- Diabetic Complications: Research is exploring how fenofibrate might help protect against kidney and eye complications in diabetes.
- Cancer Treatment: Early research is investigating whether fenofibrate could have a role in treating certain types of cancer, such as multiple myeloma.
- Weight Management: Some studies are looking at whether fenofibrate, when combined with other medications, could help with weight loss in obese patients.
These ongoing studies highlight the potential versatility of fenofibrate and may lead to new approved uses in the future. However, it's important to remember that fenofibrate should only be used as prescribed by a healthcare professional for approved indications.